The Effect of Dormicum-Ketamine Versus Dexmedetomidine on Emergence Delirium During Deep Sedation in Paediatric Burn Patients
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age3-16
SponsorAin Shams University
About this trial
The aim of this study is to compare the effects of dormicum-ketamine versus dexmedetomidine on postoperative emergence delirium in pediatric patients undergoing deep sedation for burn-related procedures
Eligibility criteria
Qualifiers
Age from 3 to 16 years
Both sexes
Patients classified as American Society of Anesthesiologists (ASA) Physical -Status I-II
Patients scheduled for elective burn-related procedures (e.g., burn dressing changes or minor interventions)
Disqualifiers
Refusal or inability to provide written informed consent from parent or legal guardian
Known allergy or hypersensitivity to any of the study medications (midazolam, ketamine, or dexmedetomidine)
Presence of hepatic dysfunction
Presence of renal dysfunction
Trial design
Treatments tested in this trial
- Midazolam + Ketamine
- Dexmedetomidine (DEX)
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov